Open-Label Treatment With MPC-7869 for Patients With Alzheimer's Who Previously Participated in an MPC-7869 Protocol

This study has been terminated.

( Myriad has discontinued the development of Flurizan. )

Study NCT00380276 Information provided by Myrexis Inc.

First Received: September 21, 2006 Last Updated: August 1, 2008 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Estimated Study Completion Date:	December 2008
Estimated Primary Completion Date:	No date given